Metastatic cancer is stage IV, the most advanced stage in the standard cancer staging system. This means the cancer has spread from where it originally started to distant parts of the body. Regardless of the specific cancer type, once distant spread is confirmed, the diagnosis is classified as stage IV.
How the Staging System Works
Most cancers are staged using the TNM system, maintained by the American Joint Committee on Cancer (AJCC). The three letters stand for Tumor (size and extent of the primary tumor), Nodes (whether nearby lymph nodes are involved), and Metastasis (whether cancer has spread to distant organs). When a cancer receives an M1 designation, it means distant spread has been confirmed. M0 means no distant spread has been found.
The TNM components combine into an overall stage from I through IV. Stages I through III generally describe cancer that remains in or near its original location, with increasing size or regional lymph node involvement. Stage IV is reserved specifically for cancers with distant metastasis, the M1 designation. So while a cancer can be called “advanced” at stage III, the term “metastatic” in standard staging specifically refers to stage IV.
Where Metastatic Cancer Typically Spreads
Cancer cells can potentially reach almost any organ, but certain destinations are far more common. The bones, lungs, liver, and brain are the most frequent sites of distant metastasis across many cancer types. Which organs are affected depends heavily on where the cancer started. Breast cancer, for instance, commonly spreads to bones, lungs, liver, and brain. Lung cancer frequently metastasizes to the brain, bones, and liver. Prostate cancer has a strong tendency to spread to bones.
The symptoms you experience depend on which organ is affected:
- Bone: pain, fractures, or aching that doesn’t improve with rest
- Brain: headaches, seizures, dizziness, or changes in vision
- Lungs: shortness of breath or a persistent cough
- Liver: jaundice (yellowing of the skin or eyes), abdominal swelling, or pain in the upper right abdomen
An important detail: metastatic cancer keeps its original identity. If breast cancer spreads to the liver, the tumors in the liver are still breast cancer cells, not liver cancer. This matters because treatment targets the original cancer type, not the organ where it landed.
How Metastatic Cancer Is Detected
Confirming that cancer has spread to distant sites typically involves imaging, sometimes followed by a biopsy. CT scans, bone scans, and MRI are all common tools. PET-CT scans, which combine metabolic imaging with anatomical detail, are increasingly used because they can detect smaller deposits of cancer that conventional scans might miss.
For prostate cancer specifically, a newer type of PET-CT scan that targets a protein found on prostate cancer cells has proven 27% more accurate than the standard combination of CT and bone scans (92% vs. 65% accuracy). This kind of precision matters because finding or ruling out metastasis changes the entire treatment plan. Similar advances in targeted imaging are being developed for other cancer types.
Staging scans are typically done at initial diagnosis if the cancer appears aggressive, and again if new symptoms develop during or after treatment. A biopsy of a suspected metastatic site can confirm the diagnosis and help guide treatment decisions.
Oligometastatic Disease: A Middle Ground
Not all stage IV cancers look the same. A relatively recent concept called oligometastatic disease describes situations where cancer has spread, but only to a small number of sites. This is considered an intermediate state between localized cancer and widespread metastatic disease.
The distinction matters for treatment. Early clinical evidence shows that patients with oligometastatic disease can have improved survival when doctors treat those few metastatic spots aggressively with surgery or focused radiation, on top of standard systemic therapy. Someone with a single liver metastasis from colon cancer, for example, may be a candidate for surgical removal of that spot, which is a very different outlook than someone with cancer spread throughout multiple organs. The prognosis and treatment approach can vary significantly depending on how many sites are involved and where they are.
Treatment Goals at Stage IV
For most cancer types, stage IV is not considered curable in the traditional sense. Treatment focuses on controlling the cancer’s growth, managing symptoms, and extending life while maintaining quality of life. This can include chemotherapy, targeted therapy, immunotherapy, radiation, or combinations of these.
The same treatments used with curative intent at earlier stages are often used at stage IV, but with different goals. Radiation might be directed at a bone metastasis to relieve pain rather than eliminate the cancer entirely. Chemotherapy might aim to shrink tumors enough to reduce symptoms and slow progression. These treatments fall under the broader umbrella of palliative care, which is not the same as hospice or end-of-life care. Palliative care simply means care focused on comfort and quality of life, and it can be given alongside active cancer treatment at any point.
There are exceptions to the “not curable” generalization. Certain cancers, including some testicular cancers and specific types of lymphoma, can sometimes be cured even after distant spread. And as noted above, oligometastatic disease in select patients may be treated with curative intent. The landscape varies considerably depending on cancer type, the extent of spread, and how the cancer responds to available therapies.
What Stage IV Means for Survival
Survival statistics for stage IV cancer vary enormously by cancer type. Some metastatic cancers carry five-year survival rates in single digits, while others allow many patients to live for years or even decades. Metastatic prostate cancer, for example, has a much higher five-year survival rate than metastatic pancreatic cancer. Within any single cancer type, outcomes also depend on how many organs are involved, how well the cancer responds to treatment, and the patient’s overall health.
These statistics also shift over time. Immunotherapy and targeted therapies introduced in the last decade have dramatically improved outcomes for certain metastatic cancers, including melanoma and some lung cancers. Survival numbers based on older data may underestimate what current treatments can achieve. Your oncologist can give you the most relevant and up-to-date picture based on your specific diagnosis, including the cancer’s molecular characteristics and available treatment options.